close
Medical products

Utah Medical Products (NASDAQ:UTMD) and Treace Medical Concepts (NASDAQ:TMCI) Financial Comparison


Utah Medical Products (NASDAQ:UTMDGet a rating) and Treace Medical Concepts (NASDAQ: TMCIGet a rating) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their analyst recommendations, dividends, earnings, profitability, institutional ownership, valuation and risk.

Risk and Volatility

Utah Medical Products has a beta of 0.24, meaning its stock price is 76% less volatile than the S&P 500. Comparatively, Treace Medical Concepts has a beta of -0.6, meaning its stock price is 160% less volatile than the S&P 500. .

Analyst Recommendations

This is a summary of recent ratings and recommendations for Utah Medical Products and Treace Medical Concepts, as reported by MarketBeat.

Sales Ratings Hold odds Buy reviews Strong buy odds Rating
Utah Medical Products 0 0 0 0 N / A
Tracee Medical Concepts 0 0 4 0 3.00

Treace Medical Concepts has a consensus target price of $28.50, suggesting a potential upside of 75.82%. Given the likely higher upside of Treace Medical Concepts, analysts clearly believe that Treace Medical Concepts is more favorable than Utah Medical Products.

Insider and Institutional Ownership

71.4% of Utah Medical Products shares are held by institutional investors. By comparison, 34.8% of shares in Treace Medical Concepts are held by institutional investors. 6.6% of Utah Medical Products stock is held by insiders. By comparison, 41.9% of Treace Medical Concepts’ shares are held by insiders. Strong institutional ownership indicates that hedge funds, endowments, and large fund managers believe a stock will outperform the market over the long term.

Profitability

This table compares the net margins, return on equity and return on assets of Utah Medical Products and Treace Medical Concepts.

Net margins Return on equity return on assets
Utah Medical Products 30.34% 14.14% 13.03%
Tracee Medical Concepts -25.92% -28.57% -19.15%

Valuation and benefits

This table compares the gross revenue, earnings per share (EPS), and valuation of Utah Medical Products and Treace Medical Concepts.

Gross revenue Price/sales ratio Net revenue Earnings per share Price/earnings ratio
Utah Medical Products $49.05 million 6.09 $14.79 million $4.18 19.61
Tracee Medical Concepts $94.42 million 9.49 -$20.55 million ($0.50) -32.42

Utah Medical Products has higher revenue, but lower revenue than Treace Medical Concepts. Treace Medical Concepts trades at a lower price-to-earnings ratio than Utah Medical Products, indicating that it is currently the more affordable of the two stocks.

Summary

Utah Medical Products beats Treace Medical Concepts on 8 of 13 factors compared between the two stocks.

Utah Medical Products Company Profile (Get a rating)

Utah Medical Products, Inc. develops, manufactures and distributes medical devices for the healthcare industry. The Company offers fetal monitoring accessories, vacuum assisted delivery systems and other labor and delivery tools; Respiratory hoods for newborns DISPOSA-HOOD; and DELTRAN PLUS blood pressure monitoring systems. It also supplies GESCO umbilical vessel catheters; DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE Silicone Mouthguards; URI-CATH urinary drainage systems; NUTRI-CATHNUTRI-LOK feeding device; MYELO-NATE Lumbar Sampling Kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. Additionally, the Company offers the LETZ System for excision of cervical intraepithelial neoplasia and other lower genital tract lesions; FINESSE+ generators; loop, ball and needle electrodes; FILTRESSE spillways; other electrodes and specialized supplies and gynecological tools; Femcare trocars, cannulas, laparoscopic instruments and accessories; and EPITOME and OptiMicro electrosurgical devices. In addition, it provides Filshie Clip female surgical contraceptive devices; PATHFINDER PLUS endoscopic irrigation devices; suprapubic catheterization; LIBERTY Urinary Incontinence Treatment and Control Systems; ENDOCURETTE, a curette for the removal of uterine endometrial tissue; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of the uterus; and the LUMIN tool for manipulating the uterus in laparoscopic procedures. Additionally, the company offers DELTRAN, a disposable pressure transducer; and pressure monitoring accessories, components and other castings. It serves neonatal intensive care units, labor and delivery wards, women’s health centers in hospitals, outpatient clinics and physicians’ offices through direct customer service and a force sales representatives, independent consultants and manufacturer representatives. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Treace Medical Concepts Company Profile (Get a rating)

Treace Medical Concepts, Inc., an orthopedic medical device company, is engaged in the design, manufacture and marketing of medical devices for foot and ankle surgeons in the United States. It offers a lapiplasty procedure that allows podiatric surgeons to treat all three dimensions of the bunion, providing patients with cosmetic and medical improvement. The company also provides the Precision Lapiplasty Mini-Incision System. In addition, it offers products to address ancillary surgical procedures, including akin osteotomies, Weil osteotomies, intercuneiform stabilization, inferior tarso-metatarsal joint fusions and autograft bone harvesting, as well as fusion MTP. Treace Medical Concepts, Inc. was founded in 2013 and is headquartered in Ponte Vedra Beach, Florida.



Receive daily news and reviews for Utah medical products – Enter your email address below to receive a concise daily summary of breaking news and analyst ratings for Utah Medical Products and related companies with MarketBeat.com’s free daily email newsletter.

Joan J. Dean

The author Joan J. Dean